PROCEPT BioRobotics stock falls 4.04 percent on Nasdaq

PROCEPT BioRobotics stock was trading at USD 17.36 on Nasdaq on September 24, 2026 at 11:02 a.m. ET, down 4.04 percent from the previous close. The latest reporting backdrop is the second quarter of 2026, released on August 4, 2026, according to the company investor-relations page.

Revenue grows while losses persist

PROCEPT BioRobotics generated USD 94.498 million in second-quarter revenue, up 19.3 percent from the same quarter a year earlier, according to MarketBeat. Revenue also increased from USD 83.132 million in the first quarter of 2026 to USD 94.498 million in the second quarter, a 13.67 percent quarterly gain.

The earnings picture was less favorable. Adjusted loss per share was USD 0.47 in the second quarter, missing the USD 0.46 consensus estimate by USD 0.01, while the operating loss was USD 27.390 million and the operating margin was negative 29 percent.

Cash and analyst targets matter

Cash and cash equivalents stood at USD 227.914 million on June 30, 2026, compared with USD 245.641 million three months earlier. The balance gives investors a direct measure of financing capacity as the company continues to report operating losses.

MarketBeat lists a Hold consensus from 15 analysts and an average 12-month price target of USD 25.09. The same report cites nine Hold ratings, three Buy ratings, one Strong Buy rating and two Sell ratings, showing a divided view despite the revenue increase.

Legal risk adds another valuation variable. Business Wire reported that investors in the stated class period faced a September 22, 2026 deadline to seek appointment as lead plaintiff in a securities class action. The allegations create a separate issue from the operating figures and keep execution quality central to the stock story.

Nasdaq quote and market value

At 11:02 a.m. ET on September 24, 2026, PROCEPT BioRobotics stock stood at USD 17.36 on Nasdaq, with a market capitalization of USD 988,105,405. The 52-week range was USD 16.66 to USD 38.11, placing the quote USD 0.70 above its yearly low.